On the contrary, gene knockout studies suggest that CDC42 might also function as a tumor suppressor because targeted knockout of the CDC42 gene in hepatocytes or blood stem/progenitor cells resulted in the development of hepatocellular carcinoma or myeloproliferative disease in mice (van Hengel et al., 2008). This evidence concerns the gene CDC42 and myeloproliferative disorder.